Fresenius Medical Care AG & Co. KGaA

Research Fresenius Medical Care AG & Co. KGaA (FME) on Bullrun: market cap EUR 10.62B, P/E 12.0, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 10.62B; P/E is 12.0; dividend yield is 3.7%.

Peer valuation comparison

Latest P/E is 12.02x versus a Healthcare sector median of 24.46x (50.8% below).

Latest dividend yield is 3.72% versus a Healthcare sector median of 2.11% (76.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 19.63BEUR 978.37MEUR 1.77B25.6%n/aEUR 1.58BEUR 10.80BEUR 13.31B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-28EUR 10.62B12.03.7%1.49

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.49 EUR, yield 3.7%.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Fresenius Medical Care AG & Co. KGaA's market cap?

Fresenius Medical Care AG & Co. KGaA's market capitalization is EUR 10.62B.

What is Fresenius Medical Care AG & Co. KGaA's P/E ratio?

Fresenius Medical Care AG & Co. KGaA's price-to-earnings (P/E) ratio is 12.0.

Does Fresenius Medical Care AG & Co. KGaA pay a dividend?

Fresenius Medical Care AG & Co. KGaA has a dividend yield of 3.7%.

What does Fresenius Medical Care AG & Co. KGaA do?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.